NCT04299503Phase 2Withdrawn
Topical Crisaborole in Patients with Alopecia Areata
Phase 2 Double Blind Randomized Placebo Controlled Trial of Topical Crisaborole in Patients with Mild-to-Moderate Alopecia Areata
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Withdrawn
- Declared phase
- Phase 2
- Sponsor
- Tufts Medical Center
- Participants (registry)
- —
- Start
- March 2020 (planned)
- Primary completion
- March 2022
- Study completion
- December 2022
- Last registry update
- October 2024
- Countries
- United States
Conditions studied: Alopecia Areata
Interventions: Crisaborole Topical Ointment, Eucrisa, Placebo Topical Ointment, Placebo
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.